Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation

IntroductionTorque teno virus (TTV) replication is controlled by immune status, mirroring a degree of immunosuppression after solid organ transplantation. TTV viraemia (TTVv) was associated with acute cellular rejection and infection within the first year after liver transplantation (LT). Long-term...

Full description

Bibliographic Details
Main Authors: Bastian Engel, Irene Görzer, Alejandro Campos-Murguia, Björn Hartleben, Elisabeth Puchhammer-Stöckl, Elmar Jaeckel, Richard Taubert
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215868/full
_version_ 1827898786611986432
author Bastian Engel
Irene Görzer
Alejandro Campos-Murguia
Björn Hartleben
Elisabeth Puchhammer-Stöckl
Elmar Jaeckel
Richard Taubert
author_facet Bastian Engel
Irene Görzer
Alejandro Campos-Murguia
Björn Hartleben
Elisabeth Puchhammer-Stöckl
Elmar Jaeckel
Richard Taubert
author_sort Bastian Engel
collection DOAJ
description IntroductionTorque teno virus (TTV) replication is controlled by immune status, mirroring a degree of immunosuppression after solid organ transplantation. TTV viraemia (TTVv) was associated with acute cellular rejection and infection within the first year after liver transplantation (LT). Long-term data on TTV after LT and correlation with graft injury from protocol biopsies are limited. MethodsOne hundred plasma samples paired with graft biopsies from a prospective single-center biorepository were analyzed.ResultsThe median time post-LT was 23 months (range, 2–298). TTVv was detectable in 97%. TTVv decreased over time after LT and showed a significant decline from year 1 to later time points. Hence, TTVv correlated negatively with histologic liver fibrosis (liver allograft fibrosis and Ishak scores) and positively with the overall immunosuppression degree quantified by an immunosuppression score in the first year after LT. There was no association with dosages or trough levels of single immunosuppressants. The pharmacodynamic marker TTVv did not correlate with pharmacokinetic assessments of immunosuppression degree [calcineurin inhibitor (CNI) trough levels or immunosuppressant dosages]—our clinical gold standards to guide immunosuppressive therapy. TTVv was independently associated with histologically proven liver fibrosis after LT in the first year after LT in multivariate analysisDiscussionThe independent association of histological graft fibrosis with lower TTVv in year 1 underscores that a pharmacodynamic marker would be preferable to individualize immunosuppression after LT. However, a high variability of TTVv at the low immunosuppression doses given after the first year precludes TTV as a clinically useful marker after LT in the long-term liver transplant recipients.
first_indexed 2024-03-12T23:07:45Z
format Article
id doaj.art-937951b4531d4cc9a16f43ab405576ca
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T23:07:45Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-937951b4531d4cc9a16f43ab405576ca2023-07-18T10:12:35ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-07-011410.3389/fimmu.2023.12158681215868Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantationBastian Engel0Irene Görzer1Alejandro Campos-Murguia2Björn Hartleben3Elisabeth Puchhammer-Stöckl4Elmar Jaeckel5Richard Taubert6Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, GermanyCenter for Virology, Medical University of Vienna, Vienna, AustriaDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, GermanyInstitute for Pathology, Hannover Medical School, Hannover, GermanyCenter for Virology, Medical University of Vienna, Vienna, AustriaDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, GermanyDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, GermanyIntroductionTorque teno virus (TTV) replication is controlled by immune status, mirroring a degree of immunosuppression after solid organ transplantation. TTV viraemia (TTVv) was associated with acute cellular rejection and infection within the first year after liver transplantation (LT). Long-term data on TTV after LT and correlation with graft injury from protocol biopsies are limited. MethodsOne hundred plasma samples paired with graft biopsies from a prospective single-center biorepository were analyzed.ResultsThe median time post-LT was 23 months (range, 2–298). TTVv was detectable in 97%. TTVv decreased over time after LT and showed a significant decline from year 1 to later time points. Hence, TTVv correlated negatively with histologic liver fibrosis (liver allograft fibrosis and Ishak scores) and positively with the overall immunosuppression degree quantified by an immunosuppression score in the first year after LT. There was no association with dosages or trough levels of single immunosuppressants. The pharmacodynamic marker TTVv did not correlate with pharmacokinetic assessments of immunosuppression degree [calcineurin inhibitor (CNI) trough levels or immunosuppressant dosages]—our clinical gold standards to guide immunosuppressive therapy. TTVv was independently associated with histologically proven liver fibrosis after LT in the first year after LT in multivariate analysisDiscussionThe independent association of histological graft fibrosis with lower TTVv in year 1 underscores that a pharmacodynamic marker would be preferable to individualize immunosuppression after LT. However, a high variability of TTVv at the low immunosuppression doses given after the first year precludes TTV as a clinically useful marker after LT in the long-term liver transplant recipients.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215868/fulltorque teno (TT) virusimmunosuppressionbiomarkernon-invasive testpersonalized immunosuppressionindividualization
spellingShingle Bastian Engel
Irene Görzer
Alejandro Campos-Murguia
Björn Hartleben
Elisabeth Puchhammer-Stöckl
Elmar Jaeckel
Richard Taubert
Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
Frontiers in Immunology
torque teno (TT) virus
immunosuppression
biomarker
non-invasive test
personalized immunosuppression
individualization
title Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
title_full Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
title_fullStr Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
title_full_unstemmed Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
title_short Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
title_sort association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
topic torque teno (TT) virus
immunosuppression
biomarker
non-invasive test
personalized immunosuppression
individualization
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215868/full
work_keys_str_mv AT bastianengel associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation
AT irenegorzer associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation
AT alejandrocamposmurguia associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation
AT bjornhartleben associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation
AT elisabethpuchhammerstockl associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation
AT elmarjaeckel associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation
AT richardtaubert associationoftorquetenovirusviremiawithliverfibrosisinthefirstyearafterlivertransplantation